Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Nausea × Midazolam × Other × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Pain, Intractable 1 Neoplasms 1 Nausea 1 Dyspnea 1 Delirium 1 Death 1

Interventions

naldemedine 1 isatuximab 1 Standard of Care 1 Octreotide 1 Midazolam 1 Fecal Microbiota Transplantation 1 Dexmedetomidine 1 Aromatherapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01687751 2015-05-25

Pilot Study Comparing Treatment With Dexmedetomidine to Midazolam for Symptom Control in Advanced Cancer Patients

Fraser Health

Phase 2 Withdrawn

Death, Delirium, Dyspnea, Nausea, Neoplasms, Pain, Intractable

Data powered by HemOnc (CC BY 4.0) Colophon ⚡